Perimenopause Clinical Trials 2023

Perimenopause Clinical Trials 2023

Perimenopause research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in perimenopause clinical trials today.

Popular filter options for perimenopause trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to perimenopause

What are the top hospitals conducting perimenopause research?

While perimenopause may not receive as much attention as other medical conditions, top hospitals are still actively working to understand and address its challenges. In Santa Monica, Citruslabs is currently leading the way with one active clinical trial focused on perimenopause. Although they have yet to conduct any previous trials in this area, their commitment to researching this crucial stage of a woman's life shows promise for future breakthroughs. Similarly, St. Joseph's Healthcare Hamilton in Canada has also initiated one ongoing perimenopause trial without any prior studies completed. Across the border at the University of Delaware in Newark, researchers are delving into perimenopause with their own active clinical trial while lacking historical data from past experiments. Lastly, the UT Southwestern Medical Center in Dallas joins these efforts with an ongoing study dedicated to understanding and addressing perimenopausal symptoms—all four institutions demonstrating that even a single study can contribute significantly towards improving our understanding and management of this transitional period experienced by many women worldwide.

Which are the best cities for perimenopause clinical trials?

When it comes to perimenopause clinical trials, several cities have emerged as leaders in conducting research and development. Santa Monica, California is currently hosting 1 active trial focusing on interventions like Daily Balance Gummy and others. Hamilton, Ontario has also made strides in this area with 1 ongoing study examining Cognitive Behavioural Therapy and other potential treatments. Additionally, Newark, Delaware offers a promising clinical trial focused on Estradiol (Mylan or Vivelle Dot Patch) alongside other interventions. Finally, Dallas, Texas is actively researching the effects of Pregnenolone and various other approaches for managing perimenopausal symptoms. These cities provide individuals with opportunities to participate in innovative trials that contribute to advancements in perimenopause care.

Which are the top treatments for perimenopause being explored in clinical trials?

In the realm of perimenopause research, clinical trials are shedding light on several promising treatments. Leading the pack is hormone therapy (HT), which has shown great potential in alleviating symptoms associated with perimenopause. Another notable contender is selective estrogen receptor modulators (SERMs). This class of drugs offers a targeted approach to managing hormonal imbalances during this transitional phase. Additionally, researchers are exploring non-hormonal options such as antidepressants and botanical therapies like black cohosh to help women navigate through perimenopausal challenges. With ongoing trials, these treatments hold promise for improving quality of life for women experiencing this natural but often challenging stage of life.

What are the most recent clinical trials for perimenopause?

Recent clinical trials have aimed to address the unique challenges faced by women during perimenopause. One notable trial explored the use of estradiol, specifically in the form of Mylan or Vivelle Dot patches. This phase 4 study assessed the effectiveness and safety of these treatments for managing symptoms associated with perimenopause. Another promising avenue being investigated is pregnenolone, which has undergone phase 1 and phase 2 trials to evaluate its potential benefits in alleviating perimenopausal symptoms. As researchers continue their efforts, these studies provide hope for improved management options tailored to meet the needs of women going through this transitional period.

What perimenopause clinical trials were recently completed?

Recently, several clinical trials focused on perimenopause have completed, shedding light on potential interventions and treatments for this transitional phase in a woman's life. These studies provide valuable insights into managing the symptoms and challenges associated with perimenopause. While specific details vary across trials, their completion serves as an encouraging step forward in understanding this crucial stage of hormonal change and its impact on women's health.